ArticleGastroenterology research and practice2021

Efficacy of Neoadjuvant Chemotherapy DOX and XELOX Regimens for Patients with Resectable Gastric or Gastroesophageal Junction Adenocarcinoma.

Yuan Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.